UK Intelligence Chief Warns of Looming Geopolitical Threats Raising Investor Caution Morgan Stanley Lifts Devon Energy Price Target by 7 Signaling Confidence in EP Sector Plus500 Reports 11 Revenue Growth in Latest Quarter Reaffirms FullYear Expectations American Integrity Insurance Director Smathers Acquires 49270 in Company Stock Federal Reserve Faces Dilemma as Jobs Data Highlights Persistent CostofLiving Pressures Barclays Reports 18 Profit Increase Raises FullYear Income Guidance DocuSign Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Stock Edges Higher INCR Q2 2023 Earnings EPS Surprises 2868 Above Estimates Despite Negative Stock Reaction Brandywine Realty Trust Q1 2026 Earnings Narrow FFO Miss as Office Market Pressure Persists GDRX Q1 2026 Earnings EPS Misses Estimates Slightly as Stock Gains Despite Headwinds OXSQG Q1 2026 Earnings EPS Misses Estimates as Notes Decline TOI Q1 2026 Earnings Narrowing Losses Surprises Street Shares Edge Higher Unity Software U Gains 316 Potential Support and Resistance Levels to Monitor DAQO New Energy DQ Slides 2 as Polysilicon Oversupply Weighs on Sentiment Syndax Pharmaceuticals SNDX Holds Near Support as Biotech Sector Weighs on Sentiment Tootsie Roll Industries TR Holds Steady Near Support as Volume Remains Subdued Amylyx Pharmaceuticals AMLX Slips 25 as Biotech Sector Faces Renewed Scrutiny Chinas Humanoid Robot Ambitions Pose Growing Competition Musk Warns ASPI Q1 2026 Earnings EPS Surprise Beats Expectations Stock Declines Despite Narrower Loss Vine Hill Capital Investment Corp II VHCP Holds Steady at 995 as Key Levels Come into Focus Safehold Inc SAFE Edges Higher as Shares Approach Key Resistance Level Blue Owl Capital OBDC Slightly Down Holds Between Defined Support and Resistance Levels Mercury General MCY Edges Lower Amid Consolidation Holding Near 100 Support SmartKem Inc SMTK Declines Sharply Testing Key Support at 025 VeriSign Inc VRSN Edges Higher as Shares Test Key Levels Near 310 SEACOR Marine Holdings SMHI Slips 123 as Stock Hovers Between Key Support and Resistance Polaryx Therapeutics PLYX Slips 863 as Biotech Volatility Resurfaces Key Support Levels in Focus